YAP1 and lung carcinoma: RB1 expression was mostly associated with a wild-type (wt) exon mutation status and its functionality in YAP1-positive cell lines was suggested by decreased or absent CDKN2A/2B expression, previously shown as an alternate mechanism to disable the RB1 pathway in lung cancer [19].